Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Depo-Medrone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Depo-Medrone 40mg/1ml suspension for injection vials
1001022K0BBAAAA
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 54,412 |
|
Depo-Medrone with Lidocaine inj 1ml vials
1001022K0BBAGAG
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 34,662 |
|
Depo-Medrone with Lidocaine inj 2ml vials
1001022K0BBAFAF
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 19,998 |
|
Depo-Medrone 80mg/2ml suspension for injection vials
1001022K0BBABAB
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 13,288 |
|
Depo-Medrone 120mg/3ml suspension for injection vials
1001022K0BBAEAE
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 881 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.